期刊
BIOSENSORS & BIOELECTRONICS
卷 216, 期 -, 页码 -出版社
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2022.114673
关键词
Pathogenic bacteria; Antimicrobial probiotics; Infection inhibition; CRISPR; Cas12a; DNAzyme; Rapid detection
类别
资金
- National Natural Science Foundation of China [22074100]
- Young Elite Scientist Sponsorship Program by CAST [YESS20200036]
- Natural Science Foundation of Sichuan Province [2022NSFSC1624]
Animal bacterial infection poses an increasing threat to human health. Researchers have developed a new genetic assay that can rapidly screen antimicrobial probiotics and estimate their in vivo antimicrobial effect. This assay has been used to identify bacteria from fermented food with strong antimicrobial activity against fish pathogens.
Animal bacterial infection is increasingly threatening human health. Here we report a nucleic acid amplification -free CRISPR genetic assay that allows to rapidly screen potential food-origin antimicrobial probiotics. The assay (termed CRISPRzyme assay) is based on a CRISPR-DNAzyme cascade, where the target gene sequentially acti-vated Cas12a protein and DNAzyme, yielding a limit of detection of 62 CFU Vibrio parahaemolyticus, 86 CFU Salmonella Typhimurium, and 82 CFU Listeria monocytogenes. The elimination of nucleic acid amplification shortens processing time and operational complexity. The assay was used to rapidly screen antimicrobial pro-biotics by end-measurement of fluorescence of pathogenic bacteria. Particularly, it can estimate the in vivo antimicrobial effect due to its capacity for pathogen quantification in complex samples. We found that isolates of Bacillus and lactic acid bacteria separated from fermented food exhibited strong antimicrobial activity for fish pathogen, Vibrio parahaemolyticus, and identified surfactin as the key antimicrobial component. The CRISPRzyme assay could ease antimicrobial probiotics screening, and constitutes a new tool for combatting pathogenic bacterial contamination and infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据